These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30004113)

  • 1. LDL-Cholesterol Is the Only Clinically Relevant Biomarker for Atherosclerotic Cardiovascular Disease (ASCVD) Risk.
    Ofori-Asenso R; Zoungas S; Tonkin A; Liew D
    Clin Pharmacol Ther; 2018 Aug; 104(2):235-238. PubMed ID: 30004113
    [No Abstract]   [Full Text] [Related]  

  • 2. LDL-Cholesterol Is Not the Only Clinically Relevant Biomarker for Coronary Artery Disease or Acute Coronary Syndrome.
    Field PA; Vasan RS
    Clin Pharmacol Ther; 2018 Aug; 104(2):232-234. PubMed ID: 30004115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk markers for coronary plaque progression and destabilization beyond LDL-cholesterol in acute coronary syndrome.
    Taguchi I; Koizumi S; Kageyama M; Nasuno T; Toyoda S; Abe S; Node K; Inoue T
    Int J Cardiol; 2014 May; 173(2):329-31. PubMed ID: 24680249
    [No Abstract]   [Full Text] [Related]  

  • 4. Circulating FABP4 is a prognostic biomarker in patients with acute coronary syndrome but not in asymptomatic individuals.
    Reiser H; Klingenberg R; Hof D; Cooksley-Decasper S; Fuchs N; Akhmedov A; Zoller S; Marques-Vidal P; Marti Soler H; Heg D; Landmesser U; Rodondi N; Mach F; Windecker S; Vollenweider P; Matter CM; Lüscher TF; von Eckardstein A; Gawinecka J
    Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1872-9. PubMed ID: 26069234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of lipid and inflammatory profiles on the morphological changes of lipid-rich plaques in patients with non-ST-segment elevated acute coronary syndrome: follow-up study by optical coherence tomography and intravascular ultrasound.
    Takarada S; Imanishi T; Ishibashi K; Tanimoto T; Komukai K; Ino Y; Kitabata H; Kubo T; Tanaka A; Kimura K; Mizukoshi M; Akasaka T
    JACC Cardiovasc Interv; 2010 Jul; 3(7):766-72. PubMed ID: 20650439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased homocysteine and lipoprotein(a) levels highlight systemic atherosclerotic burden in patients with a history of acute coronary syndromes.
    Cioni G; Marcucci R; Gori AM; Valente S; Giglioli C; Gensini GF; Abbate R; Boddi M
    J Vasc Surg; 2016 Jul; 64(1):163-70. PubMed ID: 27139787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in triglyceride, HDL-C, and non-HDL-C levels in patients with acute coronary syndrome.
    Koncsos P; Fülöp P; Juhász I; Bíró K; Márk L; Simonyi G; Paragh G
    Wien Klin Wochenschr; 2016 Dec; 128(23-24):858-863. PubMed ID: 27380508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid profile associated with coronary plaque regression in patients with acute coronary syndrome: Subanalysis of PRECISE-IVUS trial.
    Tsujita K; Yamanaga K; Komura N; Sakamoto K; Sugiyama S; Sumida H; Shimomura H; Yamashita T; Oka H; Nakao K; Nakamura S; Ishihara M; Matsui K; Sakaino N; Nakamura N; Yamamoto N; Koide S; Matsumura T; Fujimoto K; Tsunoda R; Morikami Y; Matsuyama K; Oshima S; Kaikita K; Hokimoto S; Ogawa H;
    Atherosclerosis; 2016 Aug; 251():367-372. PubMed ID: 27318866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The LDL-cholesterol to HDL-cholesterol ratio and the severity of coronary and aortic atherosclerosis.
    Momiyama Y; Ohmori R; Fayad ZA; Tanaka N; Kato R; Taniguchi H; Nagata M; Ohsuzu F
    Atherosclerosis; 2012 Jun; 222(2):577-80. PubMed ID: 22516791
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk Factors Associated with Failure to Achieve the Low Density Lipoprotein Cholesterol Therapeutic Target in Patients with Acute Coronary Syndrome: A Longitudinal, Single Centre Investigation.
    Hajahmadi Pourrafsanjani M; Khayati Shal E; Khezrpour S
    High Blood Press Cardiovasc Prev; 2019 Feb; 26(1):37-43. PubMed ID: 30684247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The burden of major adverse cardiac events in patients with coronary artery disease.
    Tsai IT; Wang CP; Lu YC; Hung WC; Wu CC; Lu LF; Chung FM; Hsu CC; Lee YJ; Yu TH
    BMC Cardiovasc Disord; 2017 Jan; 17(1):1. PubMed ID: 28052754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnostic and prognostic value of circulating microRNAs in coronary artery disease: A novel approach to disease diagnosis of stable CAD and acute coronary syndrome.
    Parizadeh SM; Ferns GA; Ghandehari M; Hassanian SM; Ghayour-Mobarhan M; Parizadeh SMR; Avan A
    J Cell Physiol; 2018 Sep; 233(9):6418-6424. PubMed ID: 29215707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LOX-1 in atherosclerotic disease.
    Sawamura T; Wakabayashi I; Okamura T
    Clin Chim Acta; 2015 Feb; 440():157-63. PubMed ID: 25463747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Routine Fractional Flow Reserve on Management Decision and 1-Year Clinical Outcome of Patients With Acute Coronary Syndromes: PRIME-FFR (Insights From the POST-IT [Portuguese Study on the Evaluation of FFR-Guided Treatment of Coronary Disease] and R3F [French FFR Registry] Integrated Multicenter Registries - Implementation of FFR [Fractional Flow Reserve] in Routine Practice).
    Van Belle E; Baptista SB; Raposo L; Henderson J; Rioufol G; Santos L; Pouillot C; Ramos R; Cuisset T; Calé R; Teiger E; Jorge E; Belle L; Machado C; Barreau D; Costa M; Hanssen M; Oliveira E; Besnard C; Costa J; Dallongeville J; Pipa J; Sideris G; Fonseca N; Bretelle C; Guardado J; Lhoest N; Silva B; Barnay P; Sousa MJ; Leborgne L; Silva JC; Vincent F; Rodrigues A; Seca L; Fernandes R; Dupouy P;
    Circ Cardiovasc Interv; 2017 Jun; 10(6):. PubMed ID: 28615234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artificial neural network modeling enhances risk stratification and can reduce downstream testing for patients with suspected acute coronary syndromes, negative cardiac biomarkers, and normal ECGs.
    Isma'eel HA; Cremer PC; Khalaf S; Almedawar MM; Elhajj IH; Sakr GE; Jaber WA
    Int J Cardiovasc Imaging; 2016 Apr; 32(4):687-96. PubMed ID: 26626458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: Results from the Dyslipidemia International Study II.
    Gitt AK; Lautsch D; Ferrières J; De Ferrari GM; Vyas A; Baxter CA; Bash LD; Ashton V; Horack M; Almahmeed W; Chiang FT; Poh KK; Brudi P; Ambegaonkar B
    Atherosclerosis; 2017 Nov; 266():158-166. PubMed ID: 29028484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Indicators of inflammation in patients with coronary atherosclerosis - role of usCRP in diagnosis and disease progression prediction].
    Samoš M; Pullmann R; Funiak S; Stančík M; Mokáň M
    Vnitr Lek; 2013 Dec; 59(12):1057-64. PubMed ID: 24350937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelets as Biomarkers of Coronary Artery Disease.
    Pasalic L; Wang SS; Chen VM
    Semin Thromb Hemost; 2016 Apr; 42(3):223-33. PubMed ID: 26926585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relation between the levels of osteoprotegerin and the degree of coronary artery disease in patients with acute coronary syndrome and stable angina pectoris.
    Aksu F; Ozçelik F; Kunduracilar H; Barutçu A; Yel M; Umit EG; Altun A
    Kardiol Pol; 2014; 72(1):34-41. PubMed ID: 24469748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs as circulating biomarkers in acute coronary syndromes: A review.
    Ahlin F; Arfvidsson J; Vargas KG; Stojkovic S; Huber K; Wojta J
    Vascul Pharmacol; 2016 Jun; 81():15-21. PubMed ID: 27084396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.